SE7602740L - N-(4-piperidinyl)-n-fenylamider och -karbamat - Google Patents

N-(4-piperidinyl)-n-fenylamider och -karbamat

Info

Publication number
SE7602740L
SE7602740L SE7602740A SE7602740A SE7602740L SE 7602740 L SE7602740 L SE 7602740L SE 7602740 A SE7602740 A SE 7602740A SE 7602740 A SE7602740 A SE 7602740A SE 7602740 L SE7602740 L SE 7602740L
Authority
SE
Sweden
Prior art keywords
phenylamides
piperidinyl
carbamate
Prior art date
Application number
SE7602740A
Other languages
Unknown language ( )
English (en)
Other versions
SE426486B (sv
Inventor
P A J Janssen
Daele G H P Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SE7602740L publication Critical patent/SE7602740L/sv
Publication of SE426486B publication Critical patent/SE426486B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7602740A 1975-03-14 1976-02-27 Analogiforfarande for framstellning av n-(4-piperidinyl)-n-fenylamider och -karbamat SE426486B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55851175A 1975-03-14 1975-03-14
US05/648,685 US3998834A (en) 1975-03-14 1976-01-13 N-(4-piperidinyl)-n-phenylamides and -carbamates

Publications (2)

Publication Number Publication Date
SE7602740L true SE7602740L (sv) 1976-09-15
SE426486B SE426486B (sv) 1983-01-24

Family

ID=27071767

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7602740A SE426486B (sv) 1975-03-14 1976-02-27 Analogiforfarande for framstellning av n-(4-piperidinyl)-n-fenylamider och -karbamat

Country Status (28)

Country Link
US (1) US3998834A (sv)
JP (1) JPS5946217B2 (sv)
AT (1) AT359493B (sv)
AU (1) AU503632B2 (sv)
BG (1) BG28259A3 (sv)
CA (1) CA1080232A (sv)
CH (1) CH629486A5 (sv)
CZ (1) CZ278060B6 (sv)
DE (1) DE2610228A1 (sv)
DK (1) DK148960C (sv)
ES (1) ES446034A1 (sv)
FI (1) FI61481C (sv)
FR (1) FR2303546A1 (sv)
GB (1) GB1538938A (sv)
HU (1) HU172963B (sv)
IE (1) IE42512B1 (sv)
IL (1) IL49204A (sv)
IT (1) IT1057988B (sv)
LU (1) LU74511A1 (sv)
NL (1) NL185279C (sv)
NO (1) NO146162C (sv)
NZ (1) NZ180096A (sv)
PH (1) PH12746A (sv)
PL (1) PL102474B1 (sv)
PT (1) PT64898B (sv)
SE (1) SE426486B (sv)
SU (1) SU1227109A3 (sv)
YU (1) YU39960B (sv)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179569A (en) * 1975-03-14 1979-12-18 Janssen Pharmaceutica N.V. N-(4-piperidinyl)-N-phenylamides
US4208418A (en) * 1975-09-23 1980-06-17 Janssen Pharmaceutica N.V. N-Aryl-N-(1-alkyl-4-piperidinyl)arylacetamides
US4225606A (en) * 1975-09-23 1980-09-30 Janssen Pharmaceutica N.V. N-Aryl-N-(1-L-4-piperidinyl)arylacetamides
FR2389622B1 (sv) * 1977-05-05 1982-05-21 Janssen Pharmaceutica Nv
US4167574A (en) * 1978-03-13 1979-09-11 Janssen Pharmaceutica, N.V. N-phenyl-N-(4-piperidinyl)amides
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
FR2608602A1 (fr) * 1986-12-23 1988-06-24 Cerm Cent Europ Rech Mauvernay Nouvelles 3-piperidineamines ou 3-azepineamines substituees, leur preparation et leurs applications en therapeutique
US4849521A (en) * 1987-11-02 1989-07-18 Boc, Inc. Stereoselective preparation of 3-substituted-4-piperidine compounds and derivatives
US4957929A (en) * 1987-11-02 1990-09-18 Boc, Inc. 4-phenyl-4-[N-(phenyl)amido]piperidine compounds and pharmaceutical compositions employing such compounds
US5013742A (en) * 1987-11-02 1991-05-07 Boc, Inc. 4-phenyl-4-N-(phenyl) amido piperidine derivatives and pharmaceutical compositions and method employing such compounds
US4921864A (en) * 1987-11-02 1990-05-01 Boc, Inc. 4-Phenyl-4-(N-(phenyl)amido) piperidine derivatives and pharmaceutical compositions and method employing such compounds
USRE33495E (en) * 1987-11-02 1990-12-18 Boc, Inc. Stereoselective preparation of 3-substituted-4-anilino-piperidine compounds and derivatives
US4791121A (en) * 1987-11-02 1988-12-13 The Boc Group, Inc. 4-phenyl-4-(N-(phenyl)amido) piperidine derivatives and pharmaceutical compositions and method employing such compounds
US4791120A (en) * 1987-12-31 1988-12-13 The Boc Group, Inc. 4-heteropentacyclic-4-[N-(phenyl)amino] piperidine derivatives and pharmaceutical compositions and method employing such compounds
US4801615A (en) * 1987-12-31 1989-01-31 The Boc Group, Inc. 4-heterohexacyclic-4-(N-(phenyl)amido) piperidine derivatives and pharmaceutical compositions and method employing such compounds
US5019583A (en) * 1989-02-15 1991-05-28 Glaxo Inc. N-phenyl-N-(4-piperidinyl)amides useful as analgesics
US5145967A (en) * 1989-04-20 1992-09-08 Anaquest, Inc. Method for preparing 4-alkoxyalkyl-4-phenylaminopiperdines and derivatives thereof
USRE34201E (en) * 1989-04-20 1993-03-23 Anaquest, Inc. N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds
US5053411A (en) * 1989-04-20 1991-10-01 Anaquest, Inc. N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds
US4939161A (en) * 1989-05-12 1990-07-03 Boc, Inc. Analgesic N-aryl-N-[1-substituted-3,5-dimethyl-4-piperidinyl]amides
US4994471A (en) * 1989-05-12 1991-02-19 Boc, Inc. N-aryl-N-(1-substituted-3-alkoxy-4-piperidinyl)amides and pharmaceutical compositions and methods employing such compounds
US5100903A (en) * 1989-05-12 1992-03-31 Anaquest, Inc. N-aryl-n-(1-substituted-3-alkoxy-4-piperidinyl)amides and pharmaceutical compositions and methods employing such compounds
US5039804A (en) * 1989-12-13 1991-08-13 Glaxo Inc. Preparation of substituted alkali metal piperidine-4-carboxylates
US5126455A (en) * 1989-12-13 1992-06-30 Glaxo Inc. Preparation of substituted alkali metal piperidine-4-carboxylates
US5214148A (en) * 1990-12-18 1993-05-25 Glaxo Inc. Analgesic N-phenyl-N-(3-OR1 -3-ME-4-piperidinyl)amides
US5130321A (en) * 1990-12-18 1992-07-14 Glaxo Inc. Analgesic n-phenyl-n-(3-or 1-3-me-4-piperidinyl)amides
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
GB9316863D0 (en) * 1993-08-13 1993-09-29 Glaxo Group Ltd Chemical process
US5489689A (en) * 1993-09-30 1996-02-06 Mallinckrodt Chemical, Inc. Preparation of piperidine derivatives
US6541021B1 (en) * 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
EP1182192A4 (en) * 1999-04-09 2002-06-05 Mochida Pharm Co Ltd 4-HYDROXYPIPERIDINE DERIVATIVES WITH ANTI-ARRHYTHMIC EFFECT
US7361666B2 (en) * 1999-05-25 2008-04-22 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US6677332B1 (en) 1999-05-25 2004-01-13 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US6635661B2 (en) 2000-05-25 2003-10-21 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
JP2003515588A (ja) * 1999-12-06 2003-05-07 マリンクロッド・インコーポレイテッド アルフェンタニル、スフェンタニルおよびレミフェンタニルの新合成法
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
EP1795526A4 (en) * 2004-09-14 2010-10-13 Nippon Chemiphar Co N-SUBSTITUTED N- (4-PIPERIDINYL) AMIDE DERIVATIVE
JP2008088057A (ja) * 2005-03-23 2008-04-17 Nippon Chemiphar Co Ltd Ｎ−置換−ｎ−（４−ピペリジニル）アミド誘導体
EP1966140A1 (en) * 2005-11-17 2008-09-10 Mallinckrodt, Inc. Process for synthesizing remifentanil
CN101374812A (zh) * 2006-01-24 2009-02-25 马林克罗特公司 合成瑞芬太尼的方法
EP1867635A1 (en) * 2006-06-15 2007-12-19 Kern Pharma, S.L. Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for their preparation
US20080009782A1 (en) * 2006-06-28 2008-01-10 Alza Corporation Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
WO2008005423A1 (en) * 2006-07-03 2008-01-10 Cambrex Charles City, Inc. Improved method of making sufentanil
US20100048908A1 (en) * 2006-11-29 2010-02-25 Brian Kai-Ming Cheng Process for Remifentanil Synthesis
US20100056574A1 (en) * 2008-09-04 2010-03-04 Mallinckrodt Inc. Crystalline Forms of Sufentanil
WO2010053944A1 (en) * 2008-11-04 2010-05-14 Cambrex Charles City, Inc. Improved method of making piperidine derivatives
WO2012037309A2 (en) 2010-09-17 2012-03-22 Mallinckrodt Llc Improved process for the preparation of sufentanil base and related compounds
EP2455377B1 (de) 2010-11-11 2014-07-09 hameln rds gmbh Synthese von Fentanyl Analoga
US20120310140A1 (en) 2010-12-01 2012-12-06 Spinal Modulation, Inc. Directed delivery of agents to neural anatomy
SG10201913593WA (en) * 2013-03-13 2020-02-27 Harvard College Stapled and stitched polypeptides and uses thereof
EP3233077A4 (en) 2014-12-19 2018-08-08 The Broad Institute Inc. Dopamine d2 receptor ligands
EP3233799B1 (en) 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamine d2 receptor ligands
BR112017025115B1 (pt) 2015-05-27 2023-03-14 Mallinckrodt Llc Processo para formar citrato de sufentanila a partir de base de sufentanila
CN106854203B (zh) * 2015-12-08 2020-12-01 江苏恩华药业股份有限公司 枸橼酸舒芬太尼的新晶型及其制备方法
ES2699636T3 (es) 2016-01-29 2019-02-12 Bioka S R O Nuevo procedimiento para la preparación de derivados de N-fenil-N-(4-piperidinil) amida, como remifentanilo y carfentanilo
CN108503579B (zh) * 2018-03-28 2021-03-26 南京医科大学 芬太尼类似物及其应用
CN113214139B (zh) * 2020-02-03 2022-03-04 江苏谛奇医药科技有限公司 哌啶酰胺类衍生物及其制备方法、其药物组合物、其单晶培养方法及其应用
CA3185469A1 (en) 2020-08-14 2022-02-17 Novartis Ag Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof
CN114262320A (zh) * 2021-12-28 2022-04-01 宜昌人福药业有限责任公司 一种利用连续流微通道反应器制备苯胺基哌啶类药物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE623427A (sv) * 1961-10-10
US3171838A (en) * 1961-10-10 1965-03-02 Res Lab Dr C Janssen N V Aroylalkyl and hydroxyaralkyl derivatives of 4-(n-arylalkanamido)-piperidines and related compounds

Also Published As

Publication number Publication date
FI760646A (sv) 1976-09-15
IE42512B1 (en) 1980-08-27
AT359493B (de) 1980-11-10
NL7602612A (nl) 1976-09-16
CH629486A5 (de) 1982-04-30
ES446034A1 (es) 1977-10-16
NZ180096A (en) 1978-06-02
GB1538938A (en) 1979-01-24
NL185279C (nl) 1990-03-01
FR2303546B1 (sv) 1980-11-28
FR2303546A1 (fr) 1976-10-08
PH12746A (en) 1979-08-09
DK148960B (da) 1985-12-02
LU74511A1 (sv) 1976-09-01
IT1057988B (it) 1982-03-30
DK110376A (da) 1976-09-15
ATA184676A (de) 1980-04-15
YU65276A (en) 1982-08-31
NO760591L (sv) 1976-09-15
CZ278060B6 (en) 1993-08-11
AU1200676A (en) 1977-09-22
NO146162B (no) 1982-05-03
DK148960C (da) 1986-06-23
YU39960B (en) 1985-06-30
CA1080232A (en) 1980-06-24
HU172963B (hu) 1979-01-28
NL185279B (nl) 1989-10-02
US3998834A (en) 1976-12-21
FI61481C (fi) 1982-08-10
DE2610228C2 (sv) 1990-04-05
JPS51115478A (en) 1976-10-12
CZ163276A3 (en) 1993-03-17
FI61481B (fi) 1982-04-30
SU1227109A3 (ru) 1986-04-23
IE42512L (en) 1976-09-14
SE426486B (sv) 1983-01-24
PT64898A (en) 1976-04-01
NO146162C (no) 1982-08-11
IL49204A (en) 1979-11-30
JPS5946217B2 (ja) 1984-11-10
IL49204A0 (en) 1976-05-31
AU503632B2 (en) 1979-09-13
BG28259A3 (en) 1980-03-25
PT64898B (en) 1977-08-18
DE2610228A1 (de) 1976-09-30
PL102474B1 (pl) 1979-03-31

Similar Documents

Publication Publication Date Title
SE7602740L (sv) N-(4-piperidinyl)-n-fenylamider och -karbamat
FR2299944A1 (fr) Etau
ATA273676A (de) Ablenkjoch
AT361361B (de) Skiroller
ATA302176A (de) Mikroskopokular
SE415697B (sv) Ledanordning
DK461376A (da) N-substituerede cyclopropandicarboximidforbindelser
AT362274B (de) Skistock
ATA423676A (de) Siliermittel
FR2321880A1 (fr) N-(benzyl-substitue)alcanediamines
JPS51100390A (ja) Setsudantoishi
SE7612530L (sv) Flerverda fenolsamestrar
ATA155876A (de) Rostmatte
JPS51108851A (ja) Hikaridensoyogarasusenino setsudangu
ATA127576A (de) Granantwerfer-trager
JPS51102120A (ja) Kopiruseiakurironitorirukeigoseiseninoseizoho
TR19020A (tr) N-(benzensulfonil)karbamatlar-herbisid antidotlar
JPS5185010A (ja) Taabinyokuniokerutaishokukojozaino setsugohoshiki
JPS5180084A (ja) Koshitsuchojakumonono setsudanhoho
ATA33875A (de) Kopfgeleimte garnitur
JPS51105498A (ja) Netsujuseiseniseishokufuno setsudanhoho
JPS51100031A (ja) O*ssjichiorinsanjesuterunoennoseiho
JPS51108083A (ja) Shinkinasutoreputobarishin c judotaino seiho
JPS51101243A (ja) Koshuhakanetsusochi
JPS51102495A (ja) Hyojisochi

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 7602740

NAL Patent in force

Ref document number: 7602740-8

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7602740-8

Format of ref document f/p: F

SPCG Supplementary protection certificate granted

Free format text: 9490149, 910906, EXPIRES: 20010227